These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents. Costa AF. Can Assoc Radiol J; 2020 Nov 21; 71(4):536. PubMed ID: 32063014 [No Abstract] [Full Text] [Related]
7. Nephrogenic systemic fibrosis: the need for accurate case reporting. Spinazzi A, Kirchin MA, Pirovano G. J Magn Reson Imaging; 2009 May 21; 29(5):1240; author reply 1241. PubMed ID: 19388104 [No Abstract] [Full Text] [Related]
8. Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies. Dawson P. J Magn Reson Imaging; 2008 Oct 21; 28(4):797-804. PubMed ID: 18821621 [No Abstract] [Full Text] [Related]
16. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced? Tamburrini O, Balducci A. Radiol Med; 2012 Feb 01; 117(1):1-5. PubMed ID: 22020430 [Abstract] [Full Text] [Related]